UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 14, 2022 4:30 P.M.

Form:	S-3
CIK: 0001822462 Company Name: Foghorn Therapeutics Inc. File Number: 333-262711